Predicated on this interim analysis.

Predicated on these data indicating a statistically significant improvement in the trial’s main endpoint of PFS, Merck has stopped further enrollment in the trial, while continuing to follow surviving patients, stated Eric Rubin, M.D., vice president, Oncology, Merck Research Laboratories.. Predicated on this interim analysis, the analysis demonstrated a statistically significant improvement in the primary endpoint of median progression-free of charge survival in patients receiving single-agent ridaforolimus in comparison to patients receiving standard-of-care announced the National Heart, Lung, and Bloodstream Institute has awarded a $1 million Cardiac Translational Research Implementation Plan grant to support research on Glial Development Aspect 2 , a novel investigational agent for the treatment of patients with heart failure under development at Acorda. The grant, supporting both medical and laboratory studies, was awarded to Acorda and Vanderbilt University Heart and Vascular Institute jointly, which are collaborating on research of GGF2 in heart failure. The first clinical research for GGF2 in sufferers with heart failing is expected to start in mid-2010.D., Ph.D., Vice President of Preclinical Development at Acorda.